- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
U.K. study strengthens case for breast MR screening
A multicenter study published online May 16 by The Lancet has shown that a combination of MRI and mammography offers the best means of detecting breast cancer in women with a high genetic risk for the disease.
A multicenter study published online May 16 by The Lancet has shown that a combination of MRI and mammography offers the best means of detecting breast cancer in women with a high genetic risk for the disease.
The investigators found MRI significantly more sensitive than mammography (77% versus 40%) in detecting breast cancers across the group of 649 women. Combining the results increased the sensitivity to 94%. MRI proved especially effective in BRCA1 mutation carriers, in whom it detected all tumors. Both techniques were needed to spot all cancers in women carrying BRCA2 mutations.
Commenting on the study, Dr. Ellen Warner, a medical oncologist at Toronto-Sunnybrook Regional Cancer Centre, said that mammography may one day be abandoned for high-risk women.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
